J M P. H.
- Country
- Spain
- Department
- Pediatric oncology department
Research Overview
Data & Insights
Has run more than one trial at 0 of 36 partner sites.
Specializations
Pediatric Acute Myeloid Leukemia
The investigator specializes in treating acute myeloid leukemia (AML) in children, adolescents, and young adults, with particular emphasis on developing innovative therapeutic approaches.
- Pediatric AML treatment protocols
- Early-onset leukemia management
- Risk-stratified therapy approaches
Their work encompasses comprehensive treatment strategies for patients aged 0-18 years with newly diagnosed AML.
Genetic Mutation Studies
The investigator focuses on treating AML patients with specific genetic markers, particularly those with FMS-like tyrosine kinase 3 (FLT3) mutations and internal tandem duplications (ITD).
- FLT3 mutation analysis
- Targeted therapy development
- Genetic profiling in leukemia
Their expertise includes developing targeted treatments for genetically defined subgroups of AML patients.
Treatment Innovation
The investigator leads research in novel therapeutic combinations, including the integration of targeted agents with conventional chemotherapy protocols.
- Combination therapy optimization
- Drug resistance management
- Treatment response monitoring
Their work includes evaluating new therapeutic agents and optimizing treatment protocols for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.